DSM Pharmaceutical Products will use its XD high cell density process technology to produce antibodies for a major pharma company at its Groningen, The Netherlands, and Brisbane, Australia facilities.
PR Newswire
Tuesday 19 June 2012
DSM antibody deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment